Highlights DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Market Closed - Deutsche Boerse AG Other stock markets 12:46:32 17/05/2024 pm IST			5-day change	1st Jan Change
0.84 ^EUR	+3.70%		-10.16%	+60.00%

14/05	Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says	MT
13/05	Transcript : DURECT Corporation, Q1 2024 Earnings Call, May 13, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (DRRX) DURECT CORPORATION Reports Q1 Revenue $1.8M, vs. Street Est of $2.7M	14/05	MT
DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Earnings Flash (DRRX) DURECT CORPORATION Posts Q4 Revenue $2.7M, vs. Street Est of $2.7M	28/03	MT
DURECT Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03	CI
DURECT Corporation and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for Alzet® Product Line in U.S. and Canada	04/03	CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q3 Revenue $1.7M, vs. Street Est of $2.5M	14/11	MT
DURECT Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality	08/11	CI
Durect Corporation Announces Last Patient Last Visit in Phase 2B Ahfirm Trial of Larsucosterol in Alcohol-Associated Hepatitis	07/23/07	CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q2 Revenue $2.1M, vs. Street Est of $3.2M	10/23/10	MT
DURECT Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
DURECT Corporation Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis	07/23/07	CI
DURECT Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	09/23/09	CI
Earnings Flash (DRRX) DURECT CORPORATION Posts Q1 Revenue $2.1M	09/23/09	MT
DURECT Corporation Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2A Study of Larsucosterol in Alcohol-Associated Hepatitis	10/23/10	CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q4 Revenue $3.3M, vs. Street Est of $3.5M	08/23/08	MT
DURECT Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	08/23/08	CI
Reverse Split: 1 of 10	06/22/06	FA
DURECT to Implement 1-for-10 Reverse Stock Split	29/22/29	MT
Earnings Flash (DRRX) DURECT CORPORATION Reports Q3 Revenue $12M, vs. Street Est of $13M	03/22/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Highlights

Filters